Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: Factors Associated with Liver Toxicities

Journal of Vascular and Interventional Radiology - Tập 16 Số 2 - Trang 205-213 - 2005
James E. Goin1, Riad Salem2, Brian I. Carr3, Janet Dancey4, Michael C. Soulen5, Jean-François H. Geschwind6, Kathleen Goin1, Mark Van Buskirk1, Kenneth G. Thurston1
1DataMedix Corporation
2Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois.
3Thomas E. Starzl Transplantation Institute, Pittsburgh
4NATIONAL INSTITUTES OF HEALTH
5#N# * University of Pennsylvania.
6Division of Cardiovascular and Interventional Radiology, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ingold, 1965, Radiation hepatitis, AJR Radium Ther Nucl Med, 93, 200

Fajardo, 1980, Pathogenesis of veno-occlusive liver disease after radiation, Arch Pathol Lab Med, 104, 584

Lewin, 1973, Human radiation hepatitis, Arch Pathol, 96, 21

Minsky, 1989, The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole, Cancer Treat Rev, 16, 213, 10.1016/0305-7372(89)90042-X

Dawson, 2002, Analysis of radiation-induced liver disease using the Lyman NTCP model, Int J Radiat Oncol Biol Phys, 53, 810, 10.1016/S0360-3016(02)02846-8

Robertson, 1997, Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers, Int J Radial Oncol Biol Phys, 37, 325, 10.1016/S0360-3016(96)00528-7

McGinn, 1998, Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model, J Clin Oncol, 16, 2246, 10.1200/JCO.1998.16.6.2246

Russell, 1988, Dosimetry calculations for yttrium-90 used in the treatment of liver cancer, Endocurietherapy/Hyperthermia Oncol, 4, 171

Goin, 2005, Treatment of unresectable hepatocellular carcinoma with intrahepatic Yttrium 90 microspheres: a risk-stratification analysis, J Vasc Interv Radiol, 16, 195, 10.1097/01.RVI.0000142602.79459.90

Dancey, 2000, Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres, J Nucl Med, 41, 1673

Salem, 2002, Yttrium-90 microspheres: radiation therapy for unresectable liver cancer, J Vasc Interv Radiol, 13, S223, 10.1016/S1051-0443(07)61790-4

Child, 1964, Surgery and portal hypertension, 50

Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, 646, 10.1002/bjs.1800600817

Okuda, 1985, Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients, Cancer, 6, 918, 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E

1998, A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients, Hepatology, 28, 751, 10.1002/hep.510280322

2000, Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma, Hepatology, 31, 840, 10.1053/he.2000.5628

Levy, 2002, Staging of Hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto, Gut, 50, 881, 10.1136/gut.50.6.881

Conover, 1980

Hosmer, 1989, Modelbuilding strategies and methods for logistic regression, 82

Cox, 1984

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.2307/2281868

Carr, 2002, Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients, Hepatogastroenterology, 4, 79

Ahmed, 2002, Thermal ablation therapy for hepatocellular carcinoma, J Vasc Interv Radiol, 13, S213

Ramsey, 2002, Chemoembolization of hepatocellular carcinoma, J Vasc Interv Radiol, 13, S211, 10.1016/S1051-0443(07)61789-8

Leung, 2001, Determinants of postembolization syndrome after hepatic chemoembolization, J Vasc Interv Radiol, 12, 321, 10.1016/S1051-0443(07)61911-3

1995, A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma, N Engl J Med, 332, 1256, 10.1056/NEJM199505113321903

Huang, 2002, Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test, Am J Gastroenterol, 97, 1223, 10.1111/j.1572-0241.2002.05709.x

Koda, 2004, The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma, Hepatol Res, 29, 18, 10.1016/j.hepres.2004.02.001

Puleo, 2003, Liver damage after transarterial chemoembolization without embolizing agent in unresectable hepatocellular carcinoma, Tumori, 89, 285, 10.1177/030089160308900310

Andrews, 1994, Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up, J Nucl Med, 35, 1637

Sarfaraz, 2003, Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors, Med Phys, 30, 199, 10.1118/1.1538235